A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

Summary

This study is examining how well a dry powder inhaler (DPI) of albuterol medication works to help adult and adolescent subjects 12 years of age and older with persistent asthma to improve lung function.

Timeline

Start

2010-02

Primary completion

2010-06

Completion

2010-06

Outcome

Met primary endpoint

registry Albuterol Spiromax® 180 mcg vs Placebo Inhaler; p <0.0001; Mean Difference (Final Values) 1.15 (95% CI 0.88 to 1.42); ANOVA NCT01058863 ↗

Drugs

Indications